We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.69%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
Fidelity Ethereum Fund
FETH
$1.17B
| $991 | ﹤0.01% |
63
| – | – |
2024 Q3
7 quarters
|
|
502
Joby Aviation
JOBY
$5.16B
| $892 | ﹤0.01% |
100
| – | – |
2024 Q1
9 quarters
|
|
503
Citigroup
C
$205B
| $874 | ﹤0.01% |
6
| – | – |
2020 Q1
25 quarters
|
|
504
Solaris Energy Infrastructure
SEI
$4.43B
| $812 | ﹤0.01% |
10
| – | – |
2025 Q3
3 quarters
|
|
505
Amarin Corp
AMRN
$478M
| $797 | ﹤0.01% |
50
| – | – |
2019 Q4
26 quarters
|
|
506
Aetherion Technologies Inc. Common Shares
AETR
$31.7M
| $791 | ﹤0.01% |
350
| – | – |
2022 Q2
16 quarters
|
|
507
Tempus AI
TEM
$13.1B
| $784 | ﹤0.01% |
14
-178
| -93% | -$8.92K |
2025 Q1
5 quarters
|
|
508
Sutro Biopharma
STRO
$163M
| $763 | ﹤0.01% |
23
| – | – |
2020 Q4
22 quarters
|
|
509
SPDR Gold Trust
GLD
$130B
| $736 | ﹤0.01% |
2
| – | – |
2025 Q1
5 quarters
|
|
510
Madison Square Garden
MSGE
$3.77B
| $728 | ﹤0.01% |
9
| – | – |
2023 Q4
10 quarters
|
|
511
Marathon Digital Holdings
MARA
$2.71B
| $694 | ﹤0.01% |
50
| – | – |
2019 Q4
26 quarters
|
|
512
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.33B
| $675 | ﹤0.01% |
14
| – | – |
2023 Q1
13 quarters
|
|
513
Zentalis Pharmaceuticals
ZNTL
$167M
| $630 | ﹤0.01% |
130
| – | – |
2023 Q2
12 quarters
|
|
514
Archer Aviation
ACHR
$3.15B
| $614 | ﹤0.01% |
130
| – | – |
2023 Q4
10 quarters
|
|
515
BlackRock Resources & Commodities Strategy Trust
BCX
$893M
| $595 | ﹤0.01% |
53
+1
| +2% | +$12 |
2025 Q2
4 quarters
|
|
516
Fidelity Enhanced Mid Cap Core ETF
FMDE
$8.85B
| $583 | ﹤0.01% |
14
| – | – |
2025 Q2
4 quarters
|
|
517
OptimizeRx
OPRX
$138M
| $572 | ﹤0.01% |
100
| – | – |
2021 Q1
21 quarters
|
|
518
Wendy's
WEN
$1.58B
| $538 | ﹤0.01% |
+65
| New | +$465 |
2026 Q2
0 quarters
|
|
519
SCYNEXIS
SCYX
$31.9M
| $537 | ﹤0.01% |
132
-1
| -0.8% | -$6 |
2019 Q4
26 quarters
|
|
520
DELISTED
Elme Communities
ELME
| $512 | ﹤0.01% |
347
| – | – |
2020 Q4
22 quarters
|
|
521
Lucid Motors
LCID
$1.17B
| $501 | ﹤0.01% |
75
| – | – |
2021 Q4
18 quarters
|
|
522
iShares Short Maturity Bond ETF
NEAR
$5.26B
| $476 | ﹤0.01% |
9
| – | – |
2025 Q2
4 quarters
|
|
523
Penumbra
PEN
$12.6B
| $473 | ﹤0.01% |
2
| – | – |
2025 Q4
2 quarters
|
|
524
OraSure Technologies
OSUR
$250M
| $446 | ﹤0.01% |
100
| – | – |
2022 Q1
17 quarters
|
|
525
Snap
SNAP
$9.08B
| $444 | ﹤0.01% |
100
| – | – |
2019 Q4
26 quarters
|
|
Similar funds
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.